21:55
2026-07-10
runtimewire.com
artificial-intelligence
Insilico's AI-discovered lung fibrosis drug enters Phase III
Insilico Medicine's AI-discovered lung fibrosis drug, Rentosertib, has entered Phase III clinical trials for idiopathic pulmonary fibrosis, marking a rare late-stage test for AI drug discovery. The co…